(Q53229520)

12 May 2018

title

Budesonide/formoterol improves lung function compared with budesonide alone in children with asthma. (English)

1 reference

12 May 2018

main subject

asthma

0 references

budesonide/formoterol

1 reference

2

Piotr Kuna

1 reference

12 May 2018

author name string

Petr Pohunek

series ordinal

1

1 reference

12 May 2018

Carin Jorup

series ordinal

3

1 reference

12 May 2018

Kris De Boeck

series ordinal

4

1 reference

12 May 2018

publication date

1 September 2006

1 reference

12 May 2018

Pediatric Allergy & Immunology

published in

1 reference

12 May 2018

volume

17

1 reference

12 May 2018

issue

6

1 reference

12 May 2018

page(s)

458-465

1 reference

12 May 2018

Pediatric asthma disease management

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Efficacy and safety of budesonide inhalation powder (Pulmicort Turbuhaler) during 52 weeks of treatment in adults and children with persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Third International Pediatric Consensus statement on the management of childhood asthma. International Pediatric Asthma Consensus Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Effect of long‐acting β2 agonists on exacerbation rates of asthma in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Budesonide/formoterol in a single inhaler versus inhaled corticosteroids alone in the treatment of asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Measuring quality of life in children with asthma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Lung volumes and forced ventilatory flows. Report Working Party Standardization of Lung Function Tests, European Community for Steel and Coal. Official Statement of the European Respiratory Society

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Determining a minimal important change in a disease-specific Quality of Life Questionnaire.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Improved asthma control with budesonide/formoterol in a single inhaler, compared with budesonide alone

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Once-daily budesonide/formoterol in a single inhaler in adults with moderate persistent asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Effect of inhaled formoterol and budesonide on exacerbations of asthma. Formoterol and Corticosteroids Establishing Therapy (FACET) International Study Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Low dose inhaled budesonide and formoterol in mild persistent asthma: the OPTIMA randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Budesonide/formoterol combination therapy as both maintenance and reliever medication in asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-3038.2006.00425.X

10.1111/J.1399-3038.2006.00425.X

21 January 2018

Identifiers

DOI

1 reference

12 May 2018

1 reference

12 May 2018